Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Filter

Your Filters

Publisher : springer nature

Reset filters

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Effectiveness and Safety of Upadacitinib in Treating Oligoarticular and Polyarticular Psoriatic Arthritis: Primary Analysis from the UPJOINT-Study.

Authors : Werner, Stephanie Gabriele¹ (AUTHOR); Schwarze, Ilka² (AUTHOR); Baraliakos, Xenofon³ (AUTHOR)

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p45-64. 20p.

Record details

Read Online Read More Add to Saved list

Academic Journal

A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient.

Authors : Kaeley, Gurjit S.¹ (AUTHOR) ; Kivitz, Alan² (AUTHOR); Mease, Philip³ (AUTHOR)

Source: Rheumatology & Therapy. Mar2026, p1-24. 24p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Authors : Ogdie, Alexis¹ (AUTHOR) ; Middaugh, Nicole² (AUTHOR); Blachley, Taylor² (AUTHOR)

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p195-212. 18p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study.

Authors : Gentileschi, Stefano¹ (AUTHOR); Terribili, Riccardo¹ (AUTHOR); Gaggiano, Carla¹ (AUTHOR)

Source: Scientific Reports. 2/19/2026, Vol. 16 Issue 1, p1-10. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Pharmacokinetics and Safety of Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Results of the Real-World Ustekinumab Pediatric Opportunistic Pharmacokinetics Study (U-POPS).

Authors : Lam, Edwin¹ (AUTHOR); Berezny, Katherine¹ (AUTHOR); Bishop, Corey J.¹ (AUTHOR)

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p265-278. 14p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials.

Authors : Gladman, Dafna D.¹ (AUTHOR) ; Eder, Lihi² (AUTHOR); Selmi, Carlo^3,4 (AUTHOR)

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p213-229. 17p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-Inhibitors for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons.

Authors : Mestre-Ferrandiz, Jorge¹ (AUTHOR); Navarro-Compán, Victoria² (AUTHOR); Ivanova-Markova, Yoana³ (AUTHOR)

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p83-94. 12p.

Record details

Read Online Read More Add to Saved list

Academic Journal

On-Label Treatment Persistence Through 24 Months Among Patients with Active Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Tumor Necrosis Factor Inhibitors.

Authors : Mease, Philip J.^1,2 (AUTHOR) ; Walsh, Jessica A.^3,4 (AUTHOR) ; Fitzgerald, Timothy P.⁵ (AUTHOR)

Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p115-134. 20p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year.

Authors : Thaçi, Diamant¹ (AUTHOR) ; Asahina, Akihiko² (AUTHOR); Boehncke, Wolf-Henning^3,4 (AUTHOR)

Source: Dermatology & Therapy. Feb2026, Vol. 16 Issue 2, p953-976. 24p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials.

Authors : Gossec, Laure^1,2 (AUTHOR); Sellas, Agustí³ (AUTHOR); Gruben, David C.⁴ (AUTHOR)

Source: Rheumatology & Therapy. Dec2025, Vol. 12 Issue 6, p1175-1186. 12p.

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Effectiveness and Safety of Upadacitinib in Treating Oligoarticular and Polyarticular Psoriatic Arthritis: Primary Analysis from the UPJOINT-Study.

A Narrative Review of Secukinumab in Spondyloarthritis and Psoriatic Arthritis: Treating the Whole Patient.

Effectiveness of Tofacitinib in Patients with Psoriatic Arthritis Initiating Monotherapy Versus Combination Therapy: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study.

Pharmacokinetics and Safety of Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Results of the Real-World Ustekinumab Pediatric Opportunistic Pharmacokinetics Study (U-POPS).

Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials.

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-Inhibitors for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons.

On-Label Treatment Persistence Through 24 Months Among Patients with Active Psoriatic Arthritis Initiating Guselkumab or Subcutaneous Tumor Necrosis Factor Inhibitors.

Bimekizumab Efficacy and Safety in Patients with Psoriatic Arthritis with Substantial Skin and Nail Psoriasis to 1 Year.

Response to Tofacitinib in Patients with Psoriatic Arthritis and Probable Anxiety/Depressive Disorder: A Post Hoc Analysis of Phase 3 Trials.

Contact

Follow us